Acquisitions (Schedule of Fair Value of Identifiable Assets Acquired and Liabilities Assumed) (Details) (USD $) In Millions, unless otherwise specified			0 Months Ended
	Jun. 28, 2013	Sep. 28, 2012	Oct. 01, 2012 CNS Therapeutics, Inc. [Member]
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Current assets			$ 13.3	[1]
Intangible assets			91.9
Goodwill (non-tax deductible)	532.0	507.5	24.5
Total assets acquired			129.7
Current liabilities			4.0
Deferred tax liabilities (non-current)			27.1
Contingent consideration (non-current)			6.9
Total liabilities assumed			38.0
Net assets acquired			91.7
Account receivable			3.3
Total consideration			95.0
Plus cash assumed in acquisition			3.6
Less: contingent consideration			(6.9)
Net assets acquired			$ 91.7

[1] This amount includes $3.3 million of accounts receivable, which is also the gross contractual value. As of the acquisition date, the fair value of accounts receivable approximated carrying value.